jump to content jump to footer

RACOON FADEN Project Tackles Early Detection of Adenomyosis

Endometriosis is a vastly under-researched condition affecting women, but it is finally receiving the attention it deserves through the RACOON FADEN project.

In an insightful interview, Prof. Dr. Sylvia Mechsner (Charité Berlin) and Prof. Dr. Matthias May (University Hospital Erlangen) discuss the RACOON FADEN project, which focuses on the early detection of adenomyosis, a form of endometriosis.

This project addresses a critical gap in the diagnosis and treatment of women with severe menstrual pain. The study uses MRI scans to detect early signs of adenomyosis and gain a deeper understanding of the morphology of a healthy uterus. Additionally, the interview highlights the innovative use of structured reporting and the existing RACOON infrastructure to enhance diagnostic precision and accelerate research.

Read the full interview here.

Portrait of Professor Christina Messiou, Consultant Radiologist at The Royal Marsden NHS Foundation Trust
Professor Christina Messiou, Consultant Radiologist at The Royal Marsden NHS Foundation Trust and Professor at the Institute of Cancer Research, discusses AI-powered whole-body MRI for multiple myeloma
AI-Powered Whole-Body MRI for Multiple Myeloma: Interview with Prof. Christina Messiou
Multiple myeloma poses a unique challenge for radiologists: the disease often affects the bone marrow unevenly, and conventional biopsies can only…
Read more
Interview with PD Dr. med. Thi Dan Linh Nguyen-Kim: Structured Reporting in Clinical Practice
In this interview, PD Dr. med. Thi Dan Linh Nguyen-Kim, Head of Department and Institute Director of Radiology and Nuclear Medicine at Stadtspital…
Read more
Radiologist reviewing whole-body MRI images with AI-supported tumor burden quantification for bone metastases and multiple myeloma using mint Lesion.
Mint Medical has integrated an AI algorithm developed by The Institute of Cancer Research and The Royal Marsden into mint Lesion. The solution supports bone disease assessment and treatment response evaluation in advanced prostate cancer and multiple myeloma.
The ICR and The Royal Marsden work with Mint Medical to integrate AI-powered software into cancer treatment
The Institute of Cancer Research (ICR), London, and The Royal Marsden NHS Foundation Trust have announced a new licensing agreement with MedTech…
Read more
scroll-top